Abstract: A tissue microarray includes frozen tissue cores that extend from the top of the tissue microarray to a release. The release is a material from which embedding material of the tissue microarray can easily be removed. A stiffener is used with the release to maintain a flat shape of the release. The tissue cores may be formed from whole (i.e., paraffin-free) frozen tissue. A method and tool for manufacturing the tissue microarray are also disclosed.

Abstract: Clinical data that are measured at a plurality of sequential time points are interpreted by monitoring the Z-value of the clinical data. The Z-value of the measured data is calculated at each of the time points. The calculated Z-values are plotted and compared against a pre-selected Z-value, which may be Z=5, in one exemplary embodiment. The clinical data are determined to have undergone a statistically significant change, compared to a baseline value BV of the data, when the calculated Z-value for the measured data is greater than or substantially equal to the pre-selected Z-value. In this way, signal detection from biomarker data may be enhanced. Also, the toxicity level of drugs that are tested in clinical trials may be determined in a more reliable fashion.

Abstract: A system displays time-series data, such as electrocardiographic data. The data may be displayed as a trace with markers identifying data features. The markers may be automatically sequenced by the system.